Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Cutaneous Melanoma
Regimen:
CVD (cisplatin + dacarbazine + vinblastine)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
02/19/2021
Excerpt:
Melanoma: Cutaneous...Considerations for cytotoxic agents…Other agents include dacarbazine, paclitaxel, albumin-bound paclitaxel, or cisplatin/vinblastine/dacarbazine (CVD) (category 2B for CVD)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login